SCHEMBL7459635

SCHEMBL7459635

O=c1[nH]c(=O)n(-c2ccccc2)c2ncn(Cc3ccccc3)c12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 5/20 0.62
KDM4E B2RXH2 2/20 0.56
LMNA P02545 2/20 0.56
POLB P06746 1/20 0.56
MAPK1 P28482 1/20 0.56
KMT2A Q03164 3/20 0.54
MEN1 O00255 2/20 0.54
PDE4A P27815 2/20 0.51
SMN1; SMN2 Q16637 3/20 0.50
PARN O95453 1/20 0.50
CNOT7 Q9UIV1 1/20 0.50
BRD2 P25440 1/20 0.50
BRD3 Q15059 1/20 0.50
BRDT Q58F21 1/20 0.50
HPGD P15428 1/20 0.50
ADORA2B P29275 1/20 0.49
RXFP1 Q9HBX9 1/20 0.49
PNP P00491 1/20 0.47
ALDH1A1 P00352 2/20 0.46
ADORA2A P29274 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL556233 0.85 BRD4 (0.82) BRD4KDM4ELMNAPOLBMAPK1
SCHEMBL16363917 0.83 BRD4 (0.63) BRD4KDM4ELMNAPOLBMAPK1
SCHEMBL2795748 0.83 POLB (0.75) BRD4KDM4ELMNAPOLBMAPK1
SCHEMBL554932 0.82 BRD4 (0.81) BRD4KDM4ELMNAPOLBMAPK1
SCHEMBL27794931 0.82 POLB (0.73) BRD4KDM4ELMNAPOLBMAPK1
SCHEMBL6661580 0.80 BRD4 (0.51) BRD4KDM4ELMNAPOLBMAPK1
SCHEMBL7607643 0.80 PDE4A (0.74) BRD4KDM4ELMNAPOLBMAPK1
SCHEMBL556874 0.80 BRD4 (0.66) BRD4KDM4ELMNAPOLBMAPK1
SCHEMBL555928 0.80 BRD4 (0.62) BRD4KDM4ELMNAPOLBMAPK1
SCHEMBL7604062 0.79 PNP (0.53) BRD4KDM4ELMNAPOLBMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0812844-B1 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AG (DE) 2002-10-23 EP disclosed
EP-0771813-B1 Alkylxanthine phosphonates and alkylxanthine phosphine oxydes and their use as medicines HOECHST AG (DE) 2002-01-16 EP disclosed
US-6214992-B1 THEOPHYLLINE DERIVATIVES HAVING AT LEAST ONE ETHER FUNCTION IN METHYL RADICAL; XANTHINE COMPOUNDS WITH THIS SUBSTITUTION PATTERN USED AS ANTISHOCK TREATMENT HOECHST AKTIENGESELLSCHAFT (DE) 2001-04-10 US disclosed
US-5728686-A TREATMENT OF MUSCULAR DYSTROPHY HOECHST AKTIENGESELLSCHAFT (DE) 1998-03-17 US disclosed
EP-0812844-A2 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AKTIENGESELLSCHAFT (DE) 1997-12-17 EP disclosed
EP-0771813-A1 Alkylxanthine phosphonates and alkylxanthine phosphine oxydes and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1997-05-07 EP disclosed